Continuous Intraarterial Nimodipine Infusion for the Treatment of Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage: A Retrospective, Single-Center Cohort Trial

Continuous Intraarterial Nimodipine Infusion for the Treatment of Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage: A Retrospective, Single-Center Cohort Trial

BackgroundDelayed cerebral ischemia (DCI) occurs after aneurysmal subarachnoid hemorrhage (aSAH). Continuous intraarterial nimodipine infusion (CIAN) is a promising approach in patients with intracranial large vessel vasospasm (LVV). The objective of this retrospective single-center cohort study was...

Full description

Bibliographic Details
Main Authors: Andreas Kramer, Moritz Selbach, Thomas Kerz, Axel Neulen, Marc A. Brockmann, Florian Ringel, Carolin Brockmann
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-03-01
Series:Frontiers in Neurology
Subjects:
continuous intraarterial nimodipine infusion
aneurysmal subarachnoid hemorrhage
delayed cerebral ischemia
vasospasm
infarction
clinical outcome
Online Access:https://www.frontiersin.org/articles/10.3389/fneur.2022.829938/full

Internet

https://www.frontiersin.org/articles/10.3389/fneur.2022.829938/full

Similar Items